Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC).
Asim Amin
Consultant or Advisory Role - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (I)
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Elizabeth R. Plimack
Research Funding - Bristol-Myers Squibb
Jeffrey R. Infante
No relevant relationships to disclose
Marc S. Ernstoff
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Brian I. Rini
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Pfizer
Research Funding - Acceleron Pharma; Bristol-Myers Squibb; GlaxoSmithKline; immatics; Merck; Millennium; Pfizer
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb
Jennifer J. Knox
Consultant or Advisory Role - AVEO
Research Funding - Pfizer
Sumanta Kumar Pal
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Martin Henner Voss
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Padmanee Sharma
Consultant or Advisory Role - Bristol-Myers Squibb; Dendreon; Jounce Therapeutics; MedImmune
Stock Ownership - Jounce Therapeutics
Research Funding - Bristol-Myers Squibb
Christian K. Kollmannsberger
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Pfizer
Jennifer L. Spratlin
No relevant relationships to disclose
Yun Shen
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (B)
John F. Kurland
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Paul Gagnier
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Hans J. Hammers
Research Funding - Bristol-Myers Squibb